Copyright
©The Author(s) 2019.
World J Clin Cases. Sep 26, 2019; 7(18): 2712-2721
Published online Sep 26, 2019. doi: 10.12998/wjcc.v7.i18.2712
Published online Sep 26, 2019. doi: 10.12998/wjcc.v7.i18.2712
Variable | Univariate analysis | Multivariate analysis | ||
Hazard ratio (95%CI) | P-value | Hazard ratio (95%CI) | P-value | |
Status of 14v dissection | 0.980 | 0.900 | ||
14vD (-) | 1 (ref) | 1 (ref) | ||
14vD (+) | 1.01 (0.64-1.58) | 0.97 (0.59-1.60) | ||
Age group | 0.569 | 0.234 | ||
< 65 yr | 1 (ref) | 1 (ref) | ||
≥ 65 yr | 1.15 (0.71-1.86) | 1.40 (0.80-2.45) | ||
Gender | 0.781 | |||
Male | 1 (ref) | 1 (ref) | 0.721 | |
Female | 0.94 (0.60-1.46) | 0.91 (0.56-1.50) | ||
Tumor size | 0.455 | 0.448 | ||
< 4 cm | 1 (ref) | 1 (ref) | ||
≥ 4 cm | 1.19 (0.76-1.86) | 0.82 (0.50-1.56) | ||
Histologic grade | 0.275 | 0.162 | ||
Differentiated | 1 (ref) | 1 (ref) | ||
Undifferentiated | 1.34 (0.80-2.24) | 1.51 (0.85-2.71) | ||
pT stage | 0.004 | 0.033 | ||
T1 | 1 (ref) | 1 (ref) | ||
T2 | 4.88 (1.13-20.99) | 4.97 (1.11-22.28) | ||
T3 | 8.32 (1.96-35.29) | 6.58 (1.45-29.92) | ||
T4 | 9.17 (2.2-38.21) | 7.87 (1.84-33.74) | ||
pN stage | 0.002 | 0.018 | ||
N0 | 1 (ref) | 1 (ref) | ||
N1 | 2.29 (1.07-4.90) | 2.08 (0.92-4.67) | ||
N2 | 2.18 (1.20-3.97) | 2.01 (1.06-3.81) | ||
N3a | 3.11 (1.71-5.63) | 2.82 (1.49-5.36) | ||
N3b | 4.30 (1.46-12.65) | 3.90 (1.22-12.45) | ||
Postoperative chemotherapy | 0.799 | 0.368 | ||
No | 1 (ref) | 1 (ref) | ||
Yes | 1.06 (0.67-1.70) | 0.78 (0.46-1.33) |
- Citation: Zheng C, Gao ZM, Sun AQ, Huang HB, Wang ZN, Li K, Gao S. Prognostic significance of 14v-lymph node dissection to D2 dissection for lower-third gastric cancer. World J Clin Cases 2019; 7(18): 2712-2721
- URL: https://www.wjgnet.com/2307-8960/full/v7/i18/2712.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i18.2712